Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children
Key facts
- Who runs it
- Shanghai Children's Medical Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 6 Jun 2024
- Planned end
- 30 Jun 2026
- Type of study
- Interventional
- Treatments tested
- Theraputic drug monitoring
- Isavuconazole
- Record updated
- 13 December 2024
Who can take part
- Age
- Up to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients who intend to take isavuconazole for the treatment of invasive mycosis
- Aged 0-18 years, gender unlimited
- The subject and his/her guardian are willing to comply with the procedures and operations specified in the study protocol
- The guardian of the subject and the subject of independent informed age are willing and able to provide written informed consent to participate in the study
Who cannot take part
- The subject is known to be allergic to any azole antifungal therapy or other ingredients contained in the study drug
- The researcher believes that the condition of the child may interfere with study participation or other inappropriate conditions
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn the plasma concentration of isavuconazole in pediatric patients. It will also learn about the relationship of isavuconazole plasma concentrations to efficacy and safety in pediatric patients. The main questions it aims to answer are:
Read full original descriptionShow less
What is the plasma concentration after using isavuconazole in pediatric patients? What is the effective range of plasma concentration of isavuconazole in pediatric patients? What is the safe range of plasma concentration of isavuconazole in pediatric patients? Researchers will measure the plasma concentration of isavuconazole to see whether it is appropriate.
Participants will:
Take drug isavuconazole as prescribed by the doctor;
1mL of blood is drawn 30min before the next dose.
The group in the trial
- Isavuconazole groupOther group
Theraputic drug monitoring
Treatment: Theraputic drug monitoring and Isavuconazole
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 December 2024